Professional Research Assistant
University of Colorado Anschutz Medical Campus | |
United States, Colorado, Denver | |
Mar 03, 2026 | |
|
Research Faculty
Description
Position Details Join the University of Colorado Denver Job Description The research program focuses on developing advanced optical nanoprobes to improve cancer detection and image-guided surgery for pancreatic ductal adenocarcinoma (PDAC). Our laboratory develops biocompatible, near-infrared (NIR) chemiluminescent chitosan-based nanoparticles (CNPs). By combining synthetic chemistry with in vivo optical imaging and orthotopic mouse models, we aim to accurately locate deep cancerous tissues and metastatic lymph nodes, ultimately enhancing intraoperative techniques and patient outcomes. This collaborative position directly supports our research on dual-mode chemiluminescence and fluorescence (CL/FL) imaging for guided surgery. The researcher will work extensively with orthotopic PDAC mouse models, performing cancer cell inoculation, intravenous injections, and real-time whole-body imaging using IVIS. Core duties also include conducting biodistribution and toxicity studies, ex vivo tissue imaging, and microscopic analysis using confocal laser scanning microscopy. The candidate will actively assist in data analysis to quantify nanoparticle targeting efficacy. Professional Research Assistant Qualifications you already possess (Minimum Qualifications)
Preferred Qualification to possess (Preferred Qualifications)
Knowledge, Skills, and Abilities
CU is an Equal Opportunity Employer and complies with all applicable federal, state, and local laws governing nondiscrimination in employment. We are committed to creating a workplace where all individuals are treated with respect and dignity, and we encourage individuals from all backgrounds to apply, including protected veterans and individuals with disabilities. The University will provide reasonable accommodation to applicants with disabilities throughout the employment application process. To request an accommodation pursuant to the Americans with Disabilities Act, please contact the Human Resources ADA Coordinator at workplaceengagement@ucdenver.edu. Compensation and Benefits The salary of the finalist(s) selected for this role will be set based on a variety of factors, including but not limited to, internal equity, experience, education, specialty, and training. The above salary range (or hiring range) represents the University's good faith and reasonable estimate of the range of possible compensation at the time of posting. This position is eligible for overtime compensation. Your total compensation goes beyond the number on your paycheck. The University of Colorado Denver provides generous leave, health plans and retirement contributions that add to your bottom line. Benefits statement to include in all benefits-eligible positions. See Eligibility Matrix. Benefits: https://www.cu.edu/employee-services/benefits Total Compensation Calculator: http://www.cu.edu/node/153125 Application Deadline
Required Application Materials
Questions should be directed to Jung-Jae Lee, jungjae.lee@ucdenver.edu. Background Check Policy Qualifications
Special Instructions to Applicants
:
Required Application Materials
To apply, please visit: http://www.cu.edu/cu-careers and attach: Curriculum vitae / Resume outlining experience(s). Questions should be directed to Jung-Jae Lee, jungjae.lee@ucdenver.edu. Application Materials Required : Resume/CV Application Materials Instructions : Application Deadline Applications will be accepted until the position is filled. Preference will be given to complete applications received by Mar 8, 2026, 11:59:00 PM. Those who do not apply by this date may or may not be considered. Job Category
:
Faculty
Primary Location
:
Denver
Department
:
U0001 -- Anschutz Med Campus or Denver
-
30094 - CLAS-Chemistry
Schedule
:
Part-time
Posting Date
:
Mar 3, 2026
Unposting Date
:
Mar 9, 2026, 5:59:00 AM
Posting Contact Name
:
Jung-Jae Lee
Posting Contact Email
:
jungjae.lee@ucdenver.edu
Position Number
:
00050003 | |
Mar 03, 2026